Patients with untreated depression cost 50-75% more than matched controls — not from mental health services, but from excess medical utilization. Missed appointments, medication non-adherence, uncontrolled chronic disease, and avoidable ED visits all trace back to behavioral health conditions that are underdiagnosed, undertreated, and undercoded.
Glance tracks depression screening compliance, antidepressant adherence (PDC), follow-up after initial diagnosis, and the integration points between behavioral health and primary care panels.
Schedule a Demo See FeaturesMental health conditions affect quality measures, medication adherence, utilization, and total cost of care across every other specialty. Glance makes the connection visible.
Track PHQ-9 screening rates across your panel and the broader attributed population. Identify patients screened positive who did not receive a follow-up visit within 30 days (HEDIS DSF measure). Generate worklists for care coordinators to close the screening-to-treatment gap.
Track Proportion of Days Covered for SSRIs, SNRIs, and other antidepressants. HEDIS measures both acute phase (84 days) and continuation phase (180 days) adherence. Identify patients who discontinue early — the highest-risk period for relapse and the most common adherence failure pattern.
See which of your psychiatric patients are co-managed with a PCP, which are not connected to primary care at all, and where behavioral health conditions are affecting medical measure compliance. A depressed diabetic who stops taking metformin is a behavioral health problem manifesting as an endocrine gap.
Major depression (HCC 59), bipolar disorder (HCC 59), schizophrenia (HCC 57), and substance use disorders (HCC 55/56) all carry meaningful RAF score weight. Glance identifies patients with behavioral health claims evidence who are not coded on the active problem list, and patients with coded conditions that have not been recaptured this year.
Quantify the total cost of care impact of behavioral health conditions. Compare PMPM costs for patients with and without treated behavioral health diagnoses. Show how medication adherence improvements in psychiatric patients reduce utilization across all service categories — the business case for behavioral health integration.